✦ LIBER ✦

Serum level of arginine-vasopressin influences the prognosis of extensive-disease small-cell lung cancer

✍ Scribed by Shigeki Umemura; Yoshihiko Segawa; Hiroshi Ueoka; Katsuyuki Hotta; Katsuyuki Kiura; Nagio Takigawa; Masahiro Tabata; Akihiro Bessho; Tetsu Shinkai; Mitsune Tanimoto

Book ID: 106123669
Publisher: Springer-Verlag
Year: 2007
Tongue: English
Weight: 380 KB
Volume: 133
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-007-0196-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The prognostic influence of serum neuron

The prognostic influence of serum neuron specific enolase in small cell lung cancer

✍ Cooper, EH; Jørgensen, LGM; Østerlind, K; Hansen, HH 📂 Article 📅 1988 🏛 Nature Publishing Group 🌐 English ⚖ 544 KB

Markov model and markers of small cell l

Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis

✍ Boher, J-M; Pujol, J-L; Grenier, J; Daurès, J-P 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 136 KB

Detection of the neural cell adhesion mo

Detection of the neural cell adhesion molecule (NCAM) in serum of patients with small-cell lung cancer (SCLC) with “limited” or “extensive” disease, and bone-marrow infiltration

✍ J. A. Ledermann; F. Pasini; Y. Olabiran; G. Pelosi 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 416 KB

The neural cell adhesion molecule (NCAM) is a tumourrelated antigen found on the surface of small-cell lung cancer (SCLC). NCAM exists in several molecular forms, including a soluble isoform. We have measured serum levels of NCAM using an enzyme immunoassay with 2 anltibodies, NCC-LU-246 and NCC-LU-

Role of Serum Vascular Endothelial Growt

Role of Serum Vascular Endothelial Growth Factor in the Prediction of Angiogenesis and Prognosis for Non-small Cell Lung Cancer

✍ Yuri Shimanuki; Kazuhisa Takahashi; Ri Cui; Satoshi Hori; Fumiyuki Takahashi; Hi 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 257 KB

Elevated serum levels of TPS and CYFRA 2

Elevated serum levels of TPS and CYFRA 21-1 predict poor prognosis in advanced non-small-cell lung cancer patients treated with gefitinib

✍ Fengsheng Chen; Xi Luo; Jinbiao Zhang; Yang Lu; Rongcheng Luo 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 289 KB

Treatment of poor-prognosis extensive di

Treatment of poor-prognosis extensive disease small-cell lung cancer with an all-oral regimen of etoposide and cyclophosphamide – a Southwest Oncology Group clinical and pharmacokinetic study

✍ Steven M. Grunberg; John Crowley; Kenneth R. Hande; Dori Giroux; Nikhil Munshi; 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 115 KB